Business Wire

Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter

22.2.2023 09:00:00 EET | Business Wire | Press release

Share

Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights to discover life-changing medicines, announced today the opening of their flagship integrated wet–dry laboratory. The laboratory and offices comprise 5,500 sq ft, located at the heart of London’s Knowledge Quarter, in close reach of collaborators and partners including globally renowned academic research centres and major pharma companies. Over the last year the company has grown to a 35-strong cross-disciplinary seed-stage company. The new space is another step forward in realising Relation’s ambition to establish a novel transformational approach to drug discovery.

The integrated wet–dry laboratory’s unique value for drug discovery comes from efficiently combining the most sophisticated functional genomic techniques with extraordinary computational power and machine learning. With the acquisition of genomic data from human cells, Relation obtains direct insights into critical biological relationships, which are then fed directly into the dry laboratory’s machine learning engine. The engine then automatically requests new experiments to improve its predictive ability, cutting through an otherwise undecipherable combinatorial space. This sequence of experiments is the essence of Relation’s Lab-in-the-Loop and by uniting these two technologies Relation aims to radically improve the probability of success of drug discovery and development.

“Deploying machine learning to understand such a vast array of interactions between genes, proteins and drugs holds extraordinary potential for discovering new drugs,” said Sir Paul Nurse, CEO of the Francis Crick Institute who alongside the executive team led the official opening. “It is pleasing to see Relation Therapeutics joining the Crick and other innovative bioscience enterprises in the Knowledge Quarter, further enhancing London’s already internationally distinguished bio ecosystem.”

Relation Therapeutics further announced the appointment of Dr. Edith M. Hessel, a former GSK R&D executive, as Chief Scientific Officer (CSO). Dr. Hessel will lead the drug discovery direction of the company and the progression of its pipeline to the clinic. Dr. Hessel has successfully pioneered the development of novel target discovery platforms, advanced therapeutics from inception to clinical proof of concept, and has extensive experience in founding biotech companies. As a VP at GSK, Dr. Hessel built the Refractory Respiratory Inflammation Discovery Performance Unit, which added multiple novel targets to GSK’s pipeline.

“I am absolutely delighted to be part of Relation’s mission to transform drug discovery, probing unexplored molecular target spaces for potentially life-changing medicines,” said Edith Hessel. “Relation combines a world-class team with cutting-edge technology, including access to NVIDIA’s Cambridge-1, the UK’s most powerful super-computer. Utilising first-class computational capacity to explore experimental data, clinical insights and high-resolution biology will transform drug discovery as we know it, allowing us to develop better medicines for patients.”

In addition, Relation shared their vision for indication selection, which uses a proprietary machine learning engine - SelectomaticTM - to recommend those indications where Relation’s integrated platform enables the development of transformational therapeutics. Application of this engine led to the initiation of osteoporosis as the first disease that Relation will pursue. Osteoporosis, a metabolic bone disease, is characterised by low bone density and deterioration of bone architecture, increasing the risk of fractures.1 It is estimated that there are approximately ten million people with osteoporosis in the USA alone,1 with nearly one million considered to be patients at high risk of fractures. Furthermore, in Europe, 32 million people over 50 are estimated to have osteoporosis.2 Current treatment options have a number of limitations, including safety concerns, low uptake, and limited duration of efficacy.

“The use of single-cell profiling allows our scientists to understand bone biology with exquisite detail and provides us with the unique opportunity to be at the forefront of finding a next-generation therapy for osteoporosis,” said Dr. David Roblin, Chief Executive Officer. “This access to rich single-cell data perfectly enables the power of our machine learning engine in a disease of significant unmet need.”

In their mission to discover life-changing medicines, the team at Relation Therapeutics leverages their extensive experience in building successful biotechnology businesses. This includes Dr. Charlie Roberts, the Chairperson of Relation, who is the co-founder of Freenome, a San Francisco-based company that has raised over $1bn from investors including Roche and Novartis. In June 2022, DCVC and Magnetic Ventures co-led a $25-million round of seed financing, with participation from Khosla Ventures, OMERS Ventures, and Firstminute Capital, among others.

To learn more about Relation Therapeutics, please visit: https://www.relationrx.com/.

About Relation

Relation is a biotechnology company focused on leveraging computational and experimental techniques to understand biology better. Central to Relation’s approach is its integrated wet–dry laboratory which leverages human genetics, single-cell profiling and machine learning to generate new insights with real translational validity. The company is located in London.

References

  1. Wright N, Looker A, Saag K, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520–2526.
  2. Kanis JA, et al., SCOPE 2021: a New Scorecard for Osteoporosis in Europe, Arch Osteoporos, 2021, 16(1):82.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further queries, please contact:
Dr. Rosie Rodriguez – SVP, Growth, Relation Therapeutics: rosie@relationrx.com; +44 7511 183023

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Verlinvest to Facilitate China Resources’ Full Exit From Oatly20.11.2026 23:30:00 EET | Press release

Verlinvest, the global, family-backed consumer-focused evergreen investment company, today announced it has entered into an agreement to acquire China Resources Enterprise, Limited’s (“China Resources”) indirect interests in Oatly Group AB (publ) (Nasdaq: OTLY) (“Oatly”), the world’s original and largest oat drink company. The transaction builds on Verlinvest’s investment in Oatly since 2016 and reinforces its conviction in the company’s long-term potential. A change in strategic direction of state-owned enterprise China Resources informed its decision to fully exit its investment in Oatly. China Resources worked constructively with Verlinvest to identify the best path for it to do so in recognition of the complexity of their joint holding structure. Under the agreement, Verlinvest will acquire China Resources’ indirect interests in Oatly’s equity and convertible instruments that are currently held through Verlinvest and China Resources’ joint venture vehicle, Nativus Company Limited.

Picsart Opens the AI Behind Its Platform to Developers & Businesses20.11.2026 21:54:00 EET | Press release

Picsart, the AI media production and distribution platform backed by Sequoia Capital and SoftBank Vision Fund 2, today launched Picsart Platform - a multimodal creative AI hub that gives developers the technology behind the platform used by more than 100 million people each month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120520968/en/ Picsart Opens the AI Behind Its Platform to Developers & Businesses. They can now build their own video, audio, image features using 250+ models from 30+ providers, alongside Picsart's own editing models, through one API, CLI or MCP server. As new video and image models launch every few weeks, managing separate APIs, API keys, and billing systems creates a fragmented ecosystem. By offering unified access to creative tools, Picsart Platform eliminates fragmentation for all creators, spanning independent developers and corporate marketing teams and studios, by providing access to over 25

NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 19:45:00 EET | Press release

NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create extraordinary moments for Owners, both in the air and on the ground in Kitzbühel. “Kitzbühel is synonymous

Frontgrade Technologies Help Power Critical Computing and Electronics Aboard NASA’s Roman Space Telescope20.11.2026 19:40:00 EET | Press release

Frontgrade today announced that technologies from across its space electronics portfolio are supporting multiple mission-critical systems aboard NASA’s Nancy Grace Roman Space Telescope, which successfully launched on August 30, 2026. Roman is NASA’s flagship astrophysics observatory designed to investigate dark energy, discover exoplanets and explore the evolution of the universe. Its onboard electronics include radiation-hardened processors and microelectronics, providing critical processing, communications, power-management and control functions across the spacecraft. At the centre of Roman’s computing architecture are Frontgrade Gaisler’s GR740 and GR712RC processors. The GR740 radiation-hardened quad-core LEON4FT processor serves as the computing engine for the Wildcat Processor Card, used in the spacecraft’s primary and redundant Command and Data Handling systems as well as the Instrument Command and Data Handling systems for both the Wide Field Instrument and Coronagraph Instrum

Inside Moutai House Singapore: Beyond Baijiu, A Cultural Encounter20.11.2026 17:05:00 EET | Press release

On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120301288/en/ On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. As the world’s first Moutai brand experience space built under its new SI standards, this three-storey venue brings together cultural exhibitions, baijiu tasting, distinctive dining and creative cocktails. Using Moutai as a bridge, it creates new opportunities for Chinese baijiu culture to blend with and draw inspiration from Singapore’s diverse lifestyle and cultural scene. As early as 1954, Guizhou Moutai arrived in Singapore via the Singapore River, marking its first entry into Southeast Asia, right across from Fullerton Waterboat House. 72 years later, Moutai House has found its home along the same riverbank, transforming a historic arrival into a lasting presence and turning a con

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye